Malabsorption Syndrome Market Trends and Share Analysis By Diagnosis (Tests, Imaging), Causative Diseases (Lactose Intolerance, Sprue, Cystic Fibrosis), Treatment (Gluten-Free Diet, Antidiarrheal Agents, Anti-Inflammatory Drugs), End User – Global Forecast Till 2023
Malabsorption Syndrome Market Size is expected to grow at a CAGR of 11.0% during the forecast period of 2017-2023.
Several factors such as rising cases of causative diseases, unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are propelling the growth of the global malabsorption syndrome market.
Children and adults with cystic fibrosis are at risk for low bone density, and related complications due to malabsorption of certain nutrients.
It is expected that the support provided by the government authorities for research & development and initiatives taken to improve the reimbursement policies in healthcare is likely to drive the European market.
According to the Australian Institute of Health and Welfare, in the years 2015-2016, the total health expenditure in Australia was USD 170.4 billion, which is recorded to be 3.6% higher than the expenditure of 2014-2015.
